This inventor holds 4 USPTO granted patents and 10 published patent applications. Top assignee: Alx Oncology Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Sophia Randolph
Introduction
Sophia Randolph is a prominent inventor based in Chico, California. She has made significant strides in the field of cancer treatment through her innovative research and development. With a total of three patents to her name, Randolph is dedicated to advancing medical therapies that can improve patient outcomes.
Latest Patents
Randolph's latest patents focus on combination therapies for treating cancer. One of her notable inventions involves methods of treating hematological cancers, such as myelodysplastic syndrome. This method includes administering a polypeptide that comprises a SIRPα D1 domain variant and an Fc domain variant in conjunction with a hypomethylating agent like azacitidine. Additionally, she has developed methods that combine a polypeptide with at least one chemotherapy agent and/or therapeutic antibody, along with related kits to facilitate these treatments.
Career Highlights
Sophia Randolph is currently associated with Alx Oncology Inc., where she continues her groundbreaking work in cancer research. Her contributions have been instrumental in developing therapies that target complex cancer mechanisms, showcasing her commitment to improving healthcare.
Collaborations
Randolph collaborates with esteemed colleagues, including Hong Wan and Jaume Pons, to further enhance her research efforts. Their combined expertise fosters an environment of innovation and discovery in the field of oncology.
Conclusion
Sophia Randolph's work exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations are paving the way for new cancer treatments that hold promise for many patients.